This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Olivier Dapremont
Executive Director, Technology and Innovation at SK pharmteco
Speaker

Profile

Dr Dapremont has over 30 years of experience in continuous processes for pharmaceuticals. He started his career in equipment manufacturing before moving into CDMO business. After 25 years of spearheading the R&D engineering team at AFC, he moved to the technology and Innovation group at SK Pharmteco corporation in California.

He is a recognized expert in the development of large-scale chiral separations using Simulated Moving Bed (SMB). He is the author of several articles and chapters in reference books. He is co-inventor on patents for API purification and equipment development. He is an active member of the ACS Green Chemistry.

Agenda Sessions

  • Addressing the Acetonitrile Supply by Implementing Recovery and Reuse Strategies

    1:15pm